Myricetin 3-rhamnoside

Details

Top
Internal ID 1fd8cce3-3360-4a6d-8231-e12c1ecf9346
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Flavonoid glycosides > Flavonoid O-glycosides > Flavonoid-3-O-glycosides
IUPAC Name 5,7-dihydroxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
SMILES (Canonical) CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C(=C4)O)O)O)O)O)O
SMILES (Isomeric) CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C(=C4)O)O)O)O)O)O
InChI InChI=1S/C21H20O12/c1-6-14(26)17(29)18(30)21(31-6)33-20-16(28)13-9(23)4-8(22)5-12(13)32-19(20)7-2-10(24)15(27)11(25)3-7/h2-6,14,17-18,21-27,29-30H,1H3
InChI Key DCYOADKBABEMIQ-UHFFFAOYSA-N
Popularity 8 references in papers

Physical and Chemical Properties

Top
Molecular Formula C21H20O12
Molecular Weight 464.40 g/mol
Exact Mass 464.09547607 g/mol
Topological Polar Surface Area (TPSA) 207.00 Ų
XlogP 0.50
Atomic LogP (AlogP) 0.19
H-Bond Acceptor 12
H-Bond Donor 8
Rotatable Bonds 3

Synonyms

Top
MLS000737865
Myricetin 3-O-L-rhamnoside
Rhamnoside,myricetin-3
SMR000528196
5,7-dihydroxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
Myricetin 3-O-.alpha.-L-rhamnopyranoside
Myricitrin (8CI)
CHEMBL1599224
SCHEMBL13240936
SCHEMBL22788153
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Myricetin 3-rhamnoside

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8357 83.57%
Caco-2 - 0.8068 80.68%
Blood Brain Barrier - 0.8500 85.00%
Human oral bioavailability - 0.6857 68.57%
Subcellular localzation Mitochondria 0.7163 71.63%
OATP2B1 inhibitior + 0.5893 58.93%
OATP1B1 inhibitior + 0.8799 87.99%
OATP1B3 inhibitior + 0.9188 91.88%
MATE1 inhibitior - 0.7800 78.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior - 0.7099 70.99%
P-glycoprotein inhibitior - 0.5484 54.84%
P-glycoprotein substrate - 0.6164 61.64%
CYP3A4 substrate + 0.6028 60.28%
CYP2C9 substrate - 0.7038 70.38%
CYP2D6 substrate - 0.8611 86.11%
CYP3A4 inhibition - 0.7109 71.09%
CYP2C9 inhibition - 0.8538 85.38%
CYP2C19 inhibition - 0.8339 83.39%
CYP2D6 inhibition - 0.9547 95.47%
CYP1A2 inhibition - 0.5306 53.06%
CYP2C8 inhibition + 0.8057 80.57%
CYP inhibitory promiscuity - 0.5648 56.48%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6170 61.70%
Eye corrosion - 0.9885 98.85%
Eye irritation - 0.7532 75.32%
Skin irritation - 0.6220 62.20%
Skin corrosion - 0.9360 93.60%
Ames mutagenesis + 0.5363 53.63%
Human Ether-a-go-go-Related Gene inhibition - 0.5867 58.67%
Micronuclear + 0.9100 91.00%
Hepatotoxicity - 0.5447 54.47%
skin sensitisation - 0.8874 88.74%
Respiratory toxicity + 0.5667 56.67%
Reproductive toxicity + 0.7333 73.33%
Mitochondrial toxicity + 0.6250 62.50%
Nephrotoxicity - 0.8303 83.03%
Acute Oral Toxicity (c) III 0.5184 51.84%
Estrogen receptor binding + 0.7235 72.35%
Androgen receptor binding + 0.6849 68.49%
Thyroid receptor binding + 0.5520 55.20%
Glucocorticoid receptor binding + 0.7165 71.65%
Aromatase binding - 0.5301 53.01%
PPAR gamma + 0.6887 68.87%
Honey bee toxicity - 0.8422 84.22%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity + 0.5050 50.50%
Fish aquatic toxicity + 0.9457 94.57%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL2392 P06746 DNA polymerase beta 14125.4 nM
Potency
via CMAUP
CHEMBL1287622 Q9Y468 Lethal(3)malignant brain tumor-like protein 1 707.9 nM
707.9 nM
Potency
Potency
via CMAUP
via Super-PRED
CHEMBL2608 P10253 Lysosomal alpha-glucosidase 5011.9 nM
Potency
via CMAUP
CHEMBL1293224 P10636 Microtubule-associated protein tau 31622.8 nM
39810.7 nM
Potency
Potency
via CMAUP
via CMAUP
CHEMBL1075138 Q9NUW8 Tyrosyl-DNA phosphodiesterase 1 891.3 nM
Potency
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.56% 91.11%
CHEMBL1806 P11388 DNA topoisomerase II alpha 98.01% 89.00%
CHEMBL1951 P21397 Monoamine oxidase A 96.93% 91.49%
CHEMBL2345 P51812 Ribosomal protein S6 kinase alpha 3 96.28% 95.64%
CHEMBL2581 P07339 Cathepsin D 95.10% 98.95%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 94.78% 94.00%
CHEMBL3401 O75469 Pregnane X receptor 93.15% 94.73%
CHEMBL1293249 Q13887 Kruppel-like factor 5 92.79% 86.33%
CHEMBL3714130 P46095 G-protein coupled receptor 6 92.01% 97.36%
CHEMBL3194 P02766 Transthyretin 89.65% 90.71%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.34% 95.56%
CHEMBL3060 Q9Y345 Glycine transporter 2 87.42% 99.17%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 86.81% 90.71%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 85.84% 99.15%
CHEMBL3864 Q06124 Protein-tyrosine phosphatase 2C 84.66% 94.42%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 83.84% 99.23%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 83.74% 96.09%
CHEMBL3038469 P24941 CDK2/Cyclin A 83.66% 91.38%
CHEMBL4208 P20618 Proteasome component C5 81.05% 90.00%

Cross-Links

Top
PubChem 5352000
NPASS NPC277174
ChEMBL CHEMBL1599224
LOTUS LTS0141597
wikiData Q103818281